Using a CRISPR/Cas9 approach, we generated single cell Atrx-KO clones—KO-A and KO-B—isolated from the murine CT2A glioma cell line and a polyclonal ATRX-KO derivative of the human M059J glioma cell line, along with corresponding controls. Here, ATRX is linked to central nervous system cancer.